PROFESSIONAL EDITION

The largest community of pharma leaders

Editor´s Pick

      Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab

      BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) has accepted for review...

      Humana Announces Agreement to Acquire onehome

      LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement to acquire One Homecare...

      Dr. Paul Burton to Join Moderna as Chief Medical Officer

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Paul Burton, M.D., Ph.D., F.A.C.C,...

      Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted for a...

      Recent Articles

      Post